Modeling Inflammatory Immune Cell Recruitment and Response with the Colon Intestine-Chip

Previously Aired on June 15th, 2022

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

Immune cell recruitment is a key driver of complex human diseases such as inflammatory bowel disease (IBD) but has remained challenging to model due to the biological complexity and species-specific nature of immune response.

In this webinar, we will show data on how researchers can use Emulate Organ-on-a-Chip technology to model colon-specific immune cell recruitment, including immune cell vascular attachment, migration, activation, and downstream effector functions.

The Colon Intestine-Chip is a physiologically relevant barrier model incorporating primary human colonic organoids and intestinal microvascular endothelial cells in a dynamic microenvironment with tissue-relevant mechanical forces.

By perfusing peripheral blood mononuclear cells (PBMCs) through the vascular channel in the presence of priming cytokines/chemokines, researchers can model the selective migration of ‘gut-specific' PBMCs into the epithelial channel, where they secrete IBD-associated cytokines, kick off organ-specific inflammatory cascades, and induce the hallmark ‘leaky gut’ phenotype. In addition, the model has been demonstrated to recapitulate the efficacy and mechanism of clinically relevant, anti-inflammatory IBD therapeutics.

Join this webinar to learn how you can use the Colon Intestine-Chip to develop more effective, targeted therapeutic strategies for IBD across an expanded pool of inflammatory pathways in a single model.

In this webinar, you will learn:

  • Key challenges in modeling gut inflammation-specific immune cell recruitment
  • How to use Organ-on-a-Chip technology to create a more human-relevant model of the colon
  • How the Colon Intestine-Chip can be used model immune recruitment and assess the efficacy and mechanism of action of anti-inflammatory drugs

Presenters

Presenter
Christopher Carman, PhD
(Presenter)
Director of Immunology,
Emulate
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review